This was achieved with prostasin exosomes prepared from a cell type with a full complement of relevant proteins, Calu-3 human lung cancer cells, expressing endogenous prostasin, HAI-1, and HAI-2; or HEK293T cells, with null or minimal expression levels of all three. The gene discussed is SPINT1; the disease is lung carcinoma.